Citius pharmaceuticals, inc. reports third fiscal quarter 2021 financial results and provides general business update

Cranford, n.j., aug. 12, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today reported financial results for the third fiscal quarter of 2021 ended june 30, 2021, and provided a general business update.
CTXR Ratings Summary
CTXR Quant Ranking